Abstract
Background Brain neuromaturation can be indexed using brain predicted age difference (BrainPAD), a metric derived by the application of machine learning (ML) algorithms to neuroimaging. Previous studies in youth have been limited to a single type of imaging data, single ML approach, or specific psychiatric condition. Here, we use multimodal neuroimaging and an ensemble ML algorithm to estimate BrainPAD and examine its relationship with broad measures of symptoms and functioning in youth.
Methods We used neuroimaging from eligible participants in the Healthy Brain Network (HBN, N = 498). Participants with a Child Behavior Checklist Total Problem T-Score < 60 were split into training (N=215) and test sets (N=48). Morphometry estimates (from structural MRI), white matter connectomes (from diffusion MRI), or both were fed to an automated ML pipeline to develop BrainPAD models. The most accurate model was applied to a held-out evaluation set (N=249), and the association with several psychometrics was estimated.
Results Models using morphometry and connectomes together had a mean absolute error of 1.16 years, outperforming unimodal models. After dividing participants into positive, normal, and negative BrainPAD groups, negative BrainPAD values were associated with more symptoms on the Child Behavior Checklist (negative=71.6, normal 59.0, p=0.011) and lower functioning on the Children’s Global Assessment Scale (negative=49.3, normal=58.3, p=0.002). Higher scores were associated with better performance on the Flanker task (positive=62.4, normal=52.5, p=0.006).
Conclusion These findings suggest that a multimodal approach, in combination with an ensemble method, yields a robust biomarker correlated with clinically relevant measures in youth.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We thank the Healthy Brain Network participants and the staff at the Child Mind Institute. Mr. Alex Luna received no financial support for the research, authorship, and/or publication of this article. Dr. Joel Bernanke was supported by Grant No. T32 MH016434-41. Dr. Jiook Cha was supported by Grant No. K01 MH 109836 and by the Brain Pool Program, National Research Foundation of Korea Grant No. 200-20190251. Dr. Jonathan Posner was supported by the Edwin S Webster Foundation, Suzanne Crosby Murphy Endowment under award number R01 MH036197 and UH3 OD023328.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We used neuroimaging and psychometric data from the HBN collected between 2015, when the study was initiated, through 2017, when HBN neuroimaging data was made publicly available.
http://fcon_1000.projects.nitrc.org/indi/cmi_healthy_brain_network/
